VISUDYNE

This brand name is authorized in Austria, Brazil, Canada, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Ireland, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug VISUDYNE contains one active pharmaceutical ingredient (API):

1 Verteporfin UNII 0X9PA28K43 - VERTEPORFIN

Verteporfin, also referred to as benzoporphyrin derivative monoacids (BPD-MA) consists of a 1:1 mixture of the equally active regioisomers BPD-MAC and BPD-MAD. It produces cytotoxic agents only when activated by light in the presence of oxygen. The selectivity of PDT using verteporfin is based, in addition to the localised light exposure, on selective and rapid uptake and retention of verteporfin by rapidly proliferating cells including the endothelium of choroidal neovasculature. Read about Verteporfin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
VISUDYNE Powder for solution for infusion	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01LA01	Verteporfin	S Sensory organs → S01 Ophthalmologicals → S01L Ocular vascular disorder agents → S01LA Antineovascularisation agents
Discover more medicines within S01LA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 526516402175210
Country: CA	Health Products and Food Branch	Identifier(s): 02242367
Country: EE	Ravimiamet	Identifier(s): 1012633, 1837368
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 00140001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 002616
Country: FR	Base de données publique des médicaments	Identifier(s): 64637807
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 48119
Country: HK	Department of Health Drug Office	Identifier(s): 48053
Country: JP	医薬品医療機器総合機構	Identifier(s): 1319401F1026
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1009514
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 58963
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 9059
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100106416
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W08282001
Country: SG	Health Sciences Authority	Identifier(s): 11608P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8682340179039
Country: US	FDA, National Drug Code	Identifier(s): 0187-5600
Country: ZA	Health Products Regulatory Authority	Identifier(s): 35/15.4/0139